These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34846005)
1. Design and development of an e-nose system for the diagnosis of pulmonary diseases. Binson VA; Subramoniam M Acta Bioeng Biomech; 2021; 23(1):35-44. PubMed ID: 34846005 [TBL] [Abstract][Full Text] [Related]
2. Detection of COPD and Lung Cancer with electronic nose using ensemble learning methods. V A B; Subramoniam M; Mathew L Clin Chim Acta; 2021 Dec; 523():231-238. PubMed ID: 34627826 [TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose. V A B; Subramoniam M; Mathew L Expert Rev Mol Diagn; 2021 Nov; 21(11):1223-1233. PubMed ID: 34415806 [TBL] [Abstract][Full Text] [Related]
4. Discrimination of COPD and lung cancer from controls through breath analysis using a self-developed e-nose. Binson VA; Subramoniam M; Mathew L J Breath Res; 2021 Aug; 15(4):. PubMed ID: 34243176 [TBL] [Abstract][Full Text] [Related]
5. Detection of lung cancer in exhaled breath with an electronic nose using support vector machine analysis. Tirzīte M; Bukovskis M; Strazda G; Jurka N; Taivans I J Breath Res; 2017 Aug; 11(3):036009. PubMed ID: 28585921 [TBL] [Abstract][Full Text] [Related]
6. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643 [TBL] [Abstract][Full Text] [Related]
7. Volatile signature for the early diagnosis of lung cancer. Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451 [TBL] [Abstract][Full Text] [Related]
8. A Metal Oxide Gas Sensors Array for Lung Cancer Diagnosis Through Exhaled Breath Analysis. Marzorati D; Mainardi L; Sedda G; Gasparri R; Spaggiari L; Cerveri P Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():1584-1587. PubMed ID: 31946198 [TBL] [Abstract][Full Text] [Related]
9. Recognizing lung cancer and stages using a self-developed electronic nose system. Chen K; Liu L; Nie B; Lu B; Fu L; He Z; Li W; Pi X; Liu H Comput Biol Med; 2021 Apr; 131():104294. PubMed ID: 33647830 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm. Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388 [TBL] [Abstract][Full Text] [Related]
12. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease. Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711 [TBL] [Abstract][Full Text] [Related]
13. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology. van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795 [TBL] [Abstract][Full Text] [Related]
14. The Role of Electronic Noses in Phenotyping Patients with Chronic Obstructive Pulmonary Disease. Scarlata S; Finamore P; Meszaros M; Dragonieri S; Bikov A Biosensors (Basel); 2020 Nov; 10(11):. PubMed ID: 33187142 [TBL] [Abstract][Full Text] [Related]
15. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study. Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612 [TBL] [Abstract][Full Text] [Related]
16. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437 [TBL] [Abstract][Full Text] [Related]
17. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity. Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue. Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262 [TBL] [Abstract][Full Text] [Related]
19. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose. McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482 [TBL] [Abstract][Full Text] [Related]
20. Electronic Nose Technology in Respiratory Diseases. Dragonieri S; Pennazza G; Carratu P; Resta O Lung; 2017 Apr; 195(2):157-165. PubMed ID: 28238110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]